Biohaven
- Business
Pfizer to acquire Biohaven Pharmaceuticals in $11.6B cash deal
Biohaven known for developing migraine treatment, prevention of it in adults US-based multinational biotechnology firm Pfizer announced Tuesday it will…
Read More »
Biohaven known for developing migraine treatment, prevention of it in adults US-based multinational biotechnology firm Pfizer announced Tuesday it will…
Read More »